Zobrazeno 1 - 10
of 2 374
pro vyhledávání: '"fibroscan®"'
Autor:
Ayda Esmaeili, Reza Pourahmad Azar, Mohammadreza Mohammad Hosseiniazar, Laya Hooshmand Gharabagh
Publikováno v:
Journal of General and Family Medicine, Vol 25, Iss 6, Pp 351-357 (2024)
Abstract Background The prevalence of non‐alcoholic fatty liver disease (NAFLD), which is characterized by hepatic steatosis, inflammation, and advanced fibrosis, is high among type‐2 diabetes mellitus (T2DM) patients. Empagliflozin (EMPA), a sod
Externí odkaz:
https://doaj.org/article/9a55792848b4493690518ee13ceec360
Autor:
Gracen L, Aikebuse M, Sarraf B, McPhail SM, Russell AW, O’Beirne J, Irvine KM, Williams S, Valery PC, Powell EE
Publikováno v:
Patient Preference and Adherence, Vol Volume 18, Pp 1845-1855 (2024)
Lucy Gracen,1 Melanie Aikebuse,2,3 Babak Sarraf,2– 4 Steven M McPhail,5 Anthony W Russell,6 James O’Beirne,7 Katharine M Irvine,8 Suzanne Williams,9 Patricia C Valery,4,* Elizabeth E Powell2– 4,* 1Department of Gastroenterology and Hepa
Externí odkaz:
https://doaj.org/article/10832f40cbf4427eb527e6f4fc09d346
Autor:
Somaia Mohammed Ali Mahfouz, Fatma Salah eldin Mohamed, Nivine Abdel Moneium Chalabi, Hazem Ibrahim Abdel-Rahman
Publikováno v:
The Egyptian Journal of Radiology and Nuclear Medicine, Vol 55, Iss 1, Pp 1-9 (2024)
Abstract Background The most prevalent persistent parenchymatous liver alterations in healthy individuals are thought to be hepatic steatosis. The liver biopsy is the most crucial procedure for the identification and measurement of hepatic steatosis.
Externí odkaz:
https://doaj.org/article/915a45f278d049bc86c49adee2a84d60
Publikováno v:
Revista Científica CMDLT, Vol 18, Iss Suplemento (2024)
La esteatosis hepática de origen no alcohólico, se ha convertido en una causa cada vez más frecuente de patología hepática crónica, conduciendo incluso, en ocasiones, a trasplante hepático, considerándose también un factor de riesgo independ
Externí odkaz:
https://doaj.org/article/2bdd63ed61fe455bb4223d7d9e851ad5
Autor:
Larissa Nixdorf, Lukas Hartl, Stefanie Ströhl, Daniel Moritz Felsenreich, Magdalena Mairinger, Julia Jedamzik, Paula Richwien, Behrang Mozayani, Georg Semmler, Lorenz Balcar, Michael Schwarz, Mathias Jachs, Nina Dominik, Christoph Bichler, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Felix B. Langer, David Josef Maria Bauer, Gerhard Prager
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) and related steatohepatitis (MASH) are common among obese patients and may improve after metabolic/bariatric surgery (MBS). 93 Patients undergoing MBS in 2021–2022 were prosp
Externí odkaz:
https://doaj.org/article/bb5b5f12d8734c4fa7cf92b83afbf7ba
Autor:
Mohamed M. Elhoseeny, Badawy A. Abdulaziz, Mohamed A. Mohamed, Radwa M. Elsharaby, Ghadeer M. Rashad, Amira A. A. Othman
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Objectives To determine how fetuin-A contributes to diagnosing and assessing MASLD severity. Methods Fifty MASLD patients and fifty healthy control participants were involved in this retrospective case-control research. Abdominal ultrasonogr
Externí odkaz:
https://doaj.org/article/d078042bc4e44e1b8bd65cb0854ea136
Autor:
Jeong-Ju Yoo, Sun Ah Maeng, Young Chang, Sae Hwan Lee, Soung Won Jeong, Jae Young Jang, Gab Jin Cheon, Young Seok Kim, Hong Soo Kim, Sang Gyune Kim
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Managing complications of liver cirrhosis such as varices needing treatment (VNT) and clinically significant portal hypertension (CSPH) demands precise and non-invasive diagnostic methods. This study assesses the efficacy of spleen stiffness
Externí odkaz:
https://doaj.org/article/7abdb348a4f8424bb4aede7fcb466542
Autor:
Sukaram, Thanikan a, 1, Maung, Soe Thiha a, b, 1, Chongpison, Yuda c, Jaihan, Tassanan a, Phathong, Chonlada a, Chaiteerakij, Roongruedee a, ⁎
Publikováno v:
In Annals of Hepatology January-June 2025 30(1)
Autor:
Charu Sharma, Muhammad Jawad Hashim, Javed Yasin, Mahra Rashid Salim Alnaqbi, Abdulla Saeed Ahmed Alkaabi, Mohammed Saif Mohammed Aldhaheri, Juma Alkaabi, Adnan Agha
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionMetabolic dysfunction-associated steatotic liver disease (MASLD) has become a major cause of end-stage hepatic disease worldwide requiring liver transplantation, whereas cardiovascular disease (CVD) remains the leading cause of morbidity
Externí odkaz:
https://doaj.org/article/95e7859d137249178a70980660456732
Publikováno v:
Asian Journal of Medical Sciences, Vol 15, Iss 2, Pp 98-103 (2024)
Background: Hepatitis B infection is a global public health problem. Chronic hepatitis B (CHB) infection leads to complications such as cirrhosis, liver failure, and hepatocellular carcinoma. Effective antiviral therapy significantly improves the sta
Externí odkaz:
https://doaj.org/article/04160b6ba8cc477682018cb352626699